OUR COMMITMENT TO THE ATLANTIC PROVINCES

GlaxoSmithKline is committed to the development of strong collaborations and vibrant partnerships that improve the quality of life for Canadians and people around the world. Across the country, GlaxoSmithKline works with governments, research institutions, patient groups, health-care professionals and community organizations to provide real solutions to the health-care needs of patients. Together, we can help Canadians to do more, feel better and live longer. 

PEOPLE AND FACILITIES

• GlaxoSmithKline has more than 50 employees in Atlantic Canada, with a corporate office in Halifax, Nova Scotia. 

 

RESEARCH AND DEVELOPMENT

• GlaxoSmithKline invested more than $178 million in Canadian research and development (R&D) in 2007 alone, ranking it among the top 15 contributors to R&D in Canada, across all industries.
  
  
• GlaxoSmithKline’s $22 million Pathfinders Fund for Leaders in Canadian Health Science Research was established to help Canada become a world leader in R&D. This initiative encourages health science research and fosters innovation in Canadian medical schools.
  
  

• GlaxoSmithKline provided $250,000 to the University of New Brunswick’s Forging Our Futures campaign in support of the Pediatric Obesity Clinic. This important initiative provides treatment, education and prevention programs for obese children and their parents, while conducting research to find longer term preventive solutions.
  
  

• GlaxoSmithKline contributed $500,000 to the Queen Elizabeth II Health Sciences Centre Foundation Working Miracles capital campaign to support the introduction of a primary care diabetes management research. Known as the COMPASS initiative, this multi-center study assessed the impact of introducing diabetes case managers into the family practice setting.

 

CLINICAL RESEARCH

• In 2007, GlaxoSmithKline invested close to $45 million in clinical trials in Canada, conducting more than 80 trials and enrolling well over 2,900 patients. This represents approximately six per cent of the company’s worldwide clinical trial program. The Clinical Development Group typically works on more than 35 different chemical compounds varying from phase I to phase IV trials.
  
  

• GSK supported 60 academic research proposals in 2007 with physicians across Canada.
  
  

• In 2007, GlaxoSmithKline invested more than $3 million in clinical trials in the Atlantic provinces, and employed six local clinical research coordinators.

 

INNOVATIVE PARTNERSHIPS
           

• PRIISME®, GlaxoSmithKline’s community-based chronic disease management program, helps health-care providers support patients suffering from asthma, diabetes and chronic obstructive pulmonary disease (COPD). PRIISME® projects are underway in Atlantic Canada, including projects with the South East Regional Health Authority in Moncton, River Valley Health in Fredericton, the Health Association of Prince Edward Island, Colchester East Hants Health Authority in Truro, Beasejour Health Authority in Moncton, Annapolis Valley Health District and Capital Health District in Halifax.
  
  

• To date, close to $1 million has been committed by GSK to PRIISME® partnerships in all four provinces in the Atlantic region. Through the PRIISME® framework, GSK recently contributed $150,000 towards the Community Health Team Partnership with the Capital District Health Authority in Nova Scotia.
  
  

• GlaxoSmithKline contributed $250,000 towards the development of the INSPIRE at Work asthma management program in partnership with Medavie Blue Cross. Designed to assess the impact of asthma education and support on employees, spouses and/or their children, the program has already been introduced in several workplaces in New Brunswick.
  
  

• In 2007, GlaxoSmithKline, Medavie Blue Cross and Moosehead Breweries Ltd. were jointly awarded the national Who’s Who in Workplace Health Award for their collaborative efforts in the INSPIRE@Work program.

• GlaxoSmithKline created Community Asthma Care Centres (CACCs) in partnership with Canadian hospitals. Operating in more than 50 locations across the country, CACCs help patients to better manage their asthma through education, resulting in significant savings to the health-care system.

• In Newfoundland, CACCs can be found in Gander and St. John’s; in Nova Scotia, in Kentville, Middleton, Lower Sackville, Lunenberg, and Truro; in PEI, in Charlottetown and; in New Brunswick, CACCs are located in Bathurst, Campbellton, Caraquet, Tracadie, Lameque, Miramichi, Sackville and Saint John.

 

COMMUNITY INVESTMENTS

• GlaxoSmithKline is a proud supporter of patient association support programs in Atlantic Canada, including the local branches of the Lung Association, the Canadian Diabetes Association and the Canadian Cancer Society.
  
  

• GlaxoSmithKline is committed to giving back to the communities in which our employees live and work, and annually donates a minimum of one per cent of pre-tax profits through The GlaxoSmithKline Foundation and other channels.
  
  

• GlaxoSmithKline is an active supporter of numerous community and charitable groups in Atlantic Canada, including the United Way, various hospital and research foundations, as well as initiatives related to literacy and palliative care.
  
  

• The GlaxoSmithKline Foundation, in conjunction with the Canadian Hospice Palliative Care Association and hospice palliative care organizations across the country, launched Living Lessons®. Established in 1998, the national campaign aims to raise awareness of, and support for, hospice palliative care services.
  
  

• GlaxoSmithKline is a leading contributor to Health Partners International of Canada (HPIC), a charitable organization that provides free medications, medical supplies and vaccines donated by Canada’s research-based pharmaceutical companies to developing world countries and disaster areas. Since 1994, GlaxoSmithKline has contributed almost $23 million in humanitarian product donations.

 

For further information, please contact:
Corporate Communications
GlaxoSmithKline Inc.
Tel: 905 819-3000
www.gsk.ca